Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 1396

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.41, p 0.273). This receipt's hash covers every field on it, plus the hash of receipt 1395, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 1396
    17 Oct 2026, 21:49 UTC

    CSAD

    dopamine neurons, braak

    predictionCSAD in dopamine neurons tracks Braak Lewy-body stage

    registered1bd19e1a06642adc

    discovery-0.41 p=0.273 n=9

    replication+0.23 p=0.545 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.41, p 0.273)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    377cc14a368eb39746a3d1e3…
    follows c98f11f3f7f3…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 1396: CSAD in dopamine neurons, braak

power
full sample -0.09 (p 0.728, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.08 (p 0.761, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.08 (p 0.767, n 18). could be the mix.
skeptic
leave-one-out range -0.20 to +0.05, sign flips 2; without severely affected donors -0.09 (p 0.728, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CSAD in dopamine neurons.

case closed: nothing better to follow up.